AML ETO T(8;21) GENE REARRANGEMENT QUANTITATIVE, MRD MONITOR
This assay is used for the monitoring of AML patients with known AML-ETO [AML1(CBFA2, RUNX1)-ETO (MTG8)] fusion gene transcript formed due to translocation between chromosome 8 and 21 which is associated with Acute myeloid leukemia.
Parameter(s) covered : 1
Report Frequency: Sample Mon through Sat by 10 am; Report Next working day
Special Instruction: Physician prescription with historical data is mandatory.
Price : ₹ 5600.00
Parameters
- AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE